Recombinant multi-species Pentraxin 3/PTX3 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Pentraxin 3/PTX3 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the pentraxin protein family. The expression of this protein is induced by inflammatory cytokines in response to inflammatory stimuli in several mesenchymal and epithelial cell types, particularly endothelial cells and mononuclear phagocytes. The protein promotes fibrocyte differentiation and is involved in regulating inflammation and complement activation. It also plays a role in angiogenesis and tissue remodeling. The protein serves as a biomarker for several inflammatory conditions. [provided by RefSeq, Jun 2016]
The Alternative Names of target: PTX3,Pentaxin-related protein PTX3,Pentraxin 3,Pentraxin-related protein PTX3,Ptx3,TNFAIP5,TSG-14,Tumor necrosis factor alpha-induced protein 5 (TNF alpha-induced protein 5),Tumor necrosis factor-inducible gene 14 protein (TSG-14)

Target products collectionGo to Pentraxin 3/PTX3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-SE0602-Ag-1/ GM-Tg-hg-SE0602-Ag-2 Human Pentraxin 3/PTX3 protein Human
GM-Tg-rg-SE0602-Ag-1/ GM-Tg-rg-SE0602-Ag-2 Rat Pentraxin 3/PTX3 protein Rat
GM-Tg-mg-SE0602-Ag-1/ GM-Tg-mg-SE0602-Ag-2 Mouse Pentraxin 3/PTX3 protein Mouse
GM-Tg-cynog-SE0602-Ag-1/ GM-Tg-cynog-SE0602-Ag-2 Cynomolgus/Rhesus macaque Pentraxin 3/PTX3 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-SE0602-Ag-1/ GM-Tg-felg-SE0602-Ag-2 Feline Pentraxin 3/PTX3 protein Feline
GM-Tg-cang-SE0602-Ag-1/ GM-Tg-cang-SE0602-Ag-2 Canine Pentraxin 3/PTX3 protein Canine
GM-Tg-bovg-SE0602-Ag-1/ GM-Tg-bovg-SE0602-Ag-2 Bovine Pentraxin 3/PTX3 protein Bovine
GM-Tg-equg-SE0602-Ag-1/ GM-Tg-equg-SE0602-Ag-2 Equine Pentraxin 3/PTX3 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-SE0602-Ag-1/ GM-Tg-hg-SE0602-Ag-2; GM-Tg-rg-SE0602-Ag-1/ GM-Tg-rg-SE0602-Ag-2;
GM-Tg-mg-SE0602-Ag-1/ GM-Tg-mg-SE0602-Ag-2; GM-Tg-cynog-SE0602-Ag-1/ GM-Tg-cynog-SE0602-Ag-2;
GM-Tg-felg-SE0602-Ag-1/ GM-Tg-felg-SE0602-Ag-2; GM-Tg-cang-SE0602-Ag-1/ GM-Tg-cang-SE0602-Ag-2;
GM-Tg-bovg-SE0602-Ag-1/ GM-Tg-bovg-SE0602-Ag-2; GM-Tg-equg-SE0602-Ag-1/ GM-Tg-equg-SE0602-Ag-2
Products Name Pentraxin 3/PTX3 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name Pentraxin 3/PTX3
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine Pentraxin 3/PTX3 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.